Corey Ritter

Corey Ritter is a Principal with ARCH Venture Partners, having joined the company as an Associate in 2018. Corey identifies and evaluates new life and physical science technologies, provides operating assistance to early-stage portfolio companies, and is involved in company creation. He helped form and invest in Vizgen and other companies in development. He is a Director at Slingshot Biosciences and a board observer at Vizgen, Quantum Circuits, Inc., and others. He also supported ARCH’s investment in Singleron Biotechnologies and was previously a board observer at 908 Devices (MASS).